AC-OLE-01-VA Tolerability Study in Healthy Participants Under Different Dosing Conditions

Summary

This is an open-label, 3-arm study to compare tolerability of three different titration and dosing schedules of the AC-OLE-01-VA formulation of tricaprilin. Following a screening of up to 28 days, eligible participants will be initially randomised to one of 2 arms (Arm 1 or Arm 2). Arms 1 and 2 will be completed in advance of Arm 3 with all subsequent participants allocated to Arm 3.

Timeline

Start

2022-11-14

Primary completion

2022-12-22

Completion

2023-04-03

Drugs

Indications